Schwarz Pays $22M To Settle Medicare Fraud Cases
UCB SA subsidiary Schwarz Pharma Inc. has agreed to pay $22 million to settle allegations that the company did not tell Medicare that two of its drugs were being sold without...To view the full article, register now.
Already a subscriber? Click here to view full article